• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

Professional Introduction to N-Acetyl-L-alanyl-L-glutamine (CAS No: 121574-43-4)

N-Acetyl-L-alanyl-L-glutamine (CAS No: 121574-43-4) is a synthetic dipeptide that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound, composed of N-acetylated L-alanine and L-glutamine, exhibits unique properties that make it a valuable candidate for various therapeutic applications. Its molecular structure and biological activities have been extensively studied, revealing promising potential in areas such as immunomodulation, tissue repair, and metabolic support.

The synthesis of N-Acetyl-L-alanyl-L-glutamine involves precise chemical methodologies to ensure high purity and biological efficacy. The process typically involves the condensation of N-acetylated L-alanine with L-glutamine under controlled conditions, often catalyzed by specific enzymes or chemical agents. This synthesis is optimized to minimize side reactions and maximize yield, ensuring that the final product meets stringent quality standards required for pharmaceutical applications.

Recent research has highlighted the multifaceted roles of N-Acetyl-L-alanyl-L-glutamine in cellular biology. Studies have demonstrated its ability to enhance the production of cytokines and growth factors, which are crucial for immune response modulation. This property makes it a promising candidate for therapeutic interventions in chronic inflammatory conditions and immune deficiencies. Additionally, its role in stimulating protein synthesis and tissue repair has been explored in wound healing and muscle recovery studies.

In clinical trials, N-Acetyl-L-alanyl-L-glutamine has shown potential in supporting gut barrier function, which is essential for maintaining overall health. The compound's ability to cross the blood-brain barrier has also been investigated, suggesting possible applications in neuroprotective therapies. These findings have opened new avenues for research into neurological disorders and cognitive function enhancement.

The pharmacokinetic profile of N-Acetyl-L-alanyl-L-glutamine is another area of active investigation. Studies indicate that it exhibits good bioavailability when administered orally or intravenously, allowing for versatile dosing regimens. Its stability under various storage conditions has also been assessed, ensuring that it remains effective over prolonged periods. These characteristics make it a practical candidate for formulation into different pharmaceutical dosage forms.

From a regulatory perspective, the development of N-Acetyl-L-alanyl-L-glutamine as a therapeutic agent adheres to stringent guidelines set by global health authorities. Preclinical studies have been conducted to evaluate its safety and efficacy, with results supporting its potential as a therapeutic compound. These studies have laid the groundwork for future clinical trials aimed at expanding its therapeutic applications.

The industrial production of N-Acetyl-L-alanyl-L-glutamine has also seen advancements in recent years. Innovations in synthetic chemistry and biotechnology have enabled more efficient and cost-effective manufacturing processes. These improvements have not only increased the availability of the compound but also reduced its production costs, making it more accessible for research and therapeutic use.

The future prospects of N-Acetyl-L-alanyl-L-glutamine are promising, with ongoing research exploring new applications in personalized medicine and targeted therapies. Its unique biochemical properties suggest potential synergies with other therapeutic agents, leading to combination treatments that could offer enhanced efficacy in treating complex diseases.

In summary, N-Acetyl-L-alanyl-L-glutamine (CAS No: 121574-43-4) is a versatile dipeptide with significant potential in biochemical research and pharmaceutical development. Its multifaceted biological activities, coupled with advancements in synthesis and production techniques, position it as a valuable compound for future therapeutic applications. As research continues to uncover new insights into its mechanisms of action, its role in improving human health is likely to expand further.

• 14857-82-0(Gly-gly-leu)
• 3303-34-2(L-Alanyl-L-leucine)
• 13485-59-1(L-Alanyl-L-proline)
• 869-19-2(Glycyl-L-leucine)
• 25988-63-0(Poly-L-lysine hydrobromide (MW 150000-300000))
• 35305-74-9(N-Acetyl-L-glutamine)
• 52315-75-0(N-Lauroyl-L-lysine)
• 13115-71-4(Glycyl-glutamine)
• 2490-97-3(Aceglutamide)
• 39537-23-0(L-Alanyl-L-Glutamine)